busulfan

Trials studying busulfan

• phase3A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)active not recruitingn=340
• phase2Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myelomarecruitingn=40
• phase2Itacitinib for the Prevention of Graft Versus Host Diseaseactive not recruitingn=31
• phase2JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosiscompletedn=61
• phase2High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegalyrecruitingn=30
• phase1Cryopreserved MMUD BM With PTCy for Hematologic Malignancieswithdrawn
• phase2Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromesrecruitingn=50
• phase1Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patientsactive not recruitingn=12